| General Comment | Semaphorins, or collapsins, constitute a family characterized by the presence of a conserved semaphorin domain at the N
terminus (see OMIM 601124). To identify proteins responsible for non-multidrug resistance resistance to the
chemotherapeutic agent cisplatin (CDDP), Yamada et al. (1997) introduced a CDDP-resistant human ovarian cancer cell
cDNA expression library into CDDP-sensitive cells and selected for CDDP-resistance. They isolated a cDNA encoding a
predicted protein that has 93% amino acid homology to mouse semaphorin E. The 616-amino acid human semaphorin E
contains an N-terminal signal sequence of 15 amino acids that is followed by a semaphorin domain. In vitro translation of
the semaphorin E cDNA yielded a 70-kD protein.  Semaphorins are the lignads for plexins   Tamagnone L, et al  reviewed signalling by semaphorin receptors: cell guidance and beyond.
                
                  Semaphorins are a large family of secreted or cell-bound signals, known to guide
                  axons in developing nervous tissue. They are expressed in a variety of adult and
                  embryonic tissues and are thought to have a broader spectrum of functions. Recent
                  evidence suggests that semaphorins and their receptors play a key role in the control
                  of cellular interactions, most likely in cell-cell repulsion. A subset of semaphorins
                  interacts with neuropilins - cell-surface molecules lacking a signalling-competent
                  cytoplasmic domain. Another large family of transmembrane molecules, namely
                  plexins, bind specifically to semaphorins. Thus plexins, alone, or in association with
                  neuropilins, behave as fully functional semaphorin receptors. The intracellular
                  responses elicited by plexins are unknown, but their large cytoplasmic moiety,
                  containing the strikingly conserved sex-plexin (SP) domain, is likely to trigger novel
                  signal-transduction pathways. 
 
 |